Measure Development News


2019-06-03
 

In anticipation of the 2020 reporting period, The PQR’s Measure Development Team elected to focus on the meaningful measure area of Prevention and Treatment of Opioid and Substance Use Disorders. It goes without saying that physicians and other clinicians are on the front lines of our nation’s response to the ongoing opioid crisis. To better assist them in delivering quality and safe care, the team sought to identify areas where a gap in achieving optimal care was identified. Conditions commonly seen in emergency departments (ED) such as headache, back pain, and renal colic were candidates for this year’s measure development. Identified best practices from existing guidelines and the medical literature in general served as the foundation of three proposed measures. Additionally, the team is researching ways in which clinicians utilize opioids in their usual workflow to treat patients with acutely painful conditions in the ED. An important area that has not been explored well in measure development is the variability in how cohorts of physicians and other clinicians approach similar patient populations in terms of opioid administration in the ED. The Measurement Development Team is exploring approaches to discriminate between necessary and unnecessary clinical variation in this important area.

  • PQR01: Avoidance of Opioid Medication as the First Line of Therapy for Atraumatic headache or Migraine in the Emergency Department. 
  • PQR02: Avoidance of Opioid Medication as the First Line of Therapy for Atraumatic low back pain in the Emergency Department. 
  • PQR03: Avoidance of Opioid Medication as the First Line of Therapy for Acute Renal Colic in the Emergency Department. 
  • PQR04: Minimizing the Variation of Opioid Administration in the Treatment of Acute Pain by Eligible Clinicians in the Emergency Department.